Kathryn Edwards

April 27, 2017

Faculty members join March for Science

Among the thousands of scientists and their supporters who participated in Saturday’s March for Science in Nashville and in Washington, D.C., were several faculty members from Vanderbilt University Medical Center and Vanderbilt University.

By Bill Snyder
November 10, 2016

VUSM’s MPH Program celebrates 20th anniversary

The Vanderbilt University School of Medicine Master of Public Health (MPH) Program marked its 20th anniversary during Reunion Weekend in October.

By Kathy Whitney
October 8, 2015

Creech to direct Vanderbilt Vaccine Research Program

Buddy Creech, M.D., MPH, associate professor of Pediatrics, has been named director of the Vanderbilt Vaccine Research Program (VVRP) in the Division of Pediatric Infectious Diseases.

By VUMC News and Communications
flu shot
October 6, 2015

Flu vaccine helps reduce hospitalizations due to influenza pneumonia: study

More than half of hospitalizations due to influenza pneumonia could be prevented by influenza vaccination, according to a study led by investigators at Vanderbilt University Medical Center, published this week in the Journal of the American Medical Association.

By Paul Govern
arm with IV line
July 15, 2015

Study highlights pneumonia hospitalizations among U.S. adults

Viruses, not bacteria, are the most commonly detected respiratory pathogens in U.S. adults hospitalized with pneumonia, according to a New England Journal of Medicine study released today and conducted by researchers at Centers for Disease Control and Prevention (CDC) and hospitals in Chicago and Nashville, including Vanderbilt University Medical Center.

By Craig Boerner
July 9, 2015

Gates grant bolsters study of Tdap boosters in pregnant women

Kathryn Edwards, M.D., director of the Vanderbilt Vaccine Research Program, has received a $307,000 grant from the Bill & Melinda Gates Foundation to study the immune responses of pregnant women who receive the Tdap (reduced-dose acellular pertussis vaccines combined with tetanus and diphtheria toxoids) vaccine.

By Matt Batcheldor
April 8, 2015

VU joins national effort to speed Ebola therapy testing

Vanderbilt University researchers have joined a multi-center effort led by Pennsylvania-based Inovio Pharmaceuticals Inc. to accelerate development of potential antibody therapies against the often-lethal Ebola virus.
By Bill Snyder
March 23, 2015

New systems biology method may help improve vaccine evaluation

Researchers at Vanderbilt University have found a new way to “dissect” the human immune response following influenza vaccination.
By Bill Snyder
February 26, 2015

Respiratory viruses are main childhood pneumonia culprit: Study

Respiratory viruses, not bacterial infections, are the most commonly detected causes of community-acquired pneumonia in children, according to new research released Feb. 26 in the New England Journal of Medicine.
By Christina Echegaray
September 26, 2013

Vaccine Research Program lands major NIH renewal

The Vanderbilt Vaccine Research Program has received a major contract from the National Institutes of Health to continue its work as one of the nation’s Vaccine and Treatment Evaluation Units.
By VUMC News and Communications
September 19, 2013

VU testing vaccine against new flu threat

Vanderbilt’s Vaccine and Treatment Evaluation Unit (VTEU) is one of nine U.S. sites funded by the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), to test the effectiveness of a vaccine to protect against the H7N9 bird flu that emerged in China this spring.
By VUMC News and Communications
September 12, 2013

Options to treat childhood C. diff. infection studied

After more than a month in and out of the hospital with her daughter, Kynslee, Kristen Allen felt she was at the end of her rope. Last spring, the nearly 2-year-old Columbia girl developed diarrhea that wouldn’t go away after taking antibiotics for repeated ear infections.
By VUMC News and Communications
August 22, 2013

Vaccine researchers ready as new flu strain evolves

A worrisome new avian influenza virus, called H7N9, emerged this spring in Eastern China.
By VUMC News and Communications
1 2 3